The site of VX2 tumor transplantation affects the development of hypercalcemia in rabbits

The relationship between plasma levels of 15-keto-13, 14-dihydro-prostaglandin E₂ (15K-H₂-PGE₂) and serum calcium levels was studied in nontumor-bearing rabbits and in rabbits bearing the VX₂ carcinoma intramuscularly and intra-abdominally. The plasma levels of 15K-H₂-PGE₂ in the two groups of tumor-bearing animals did not vary significantly but was several fold greater than in nontumor-bearing rabbits. Rabbits bearing the VX₂ carcinoma intramuscularly developed hypercalcemia between the second and third week after implantation of neoplastic tissue and remained hypercalcemic until they expired. The serum calcium levels in rabbits bearing the VX₂ carcinoma intra-abdominally did not vary significantly from those of nontumor-bearing rabbits. The differences in the serum calcium levels in rabbits bearing the VX₂ carcinoma at intramuscular and intra-abdominal implant sites may be related to different extents of metabolism by the lung and by the liver of prostaglandin E₂ or other cyclooxygense products of polyenoic fatty acids produced by the tumor.